Literature DB >> 8159674

B lymphopoiesis: global factors, local control.

P W Kincade1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8159674      PMCID: PMC43478          DOI: 10.1073/pnas.91.8.2888

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  26 in total

Review 1.  Molecular interactions between stromal cells and B lymphocyte precursors.

Authors:  P W Kincade
Journal:  Semin Immunol       Date:  1991-11       Impact factor: 11.130

2.  Stimulation of B-cell progenitors by cloned murine interleukin-7.

Authors:  A E Namen; S Lupton; K Hjerrild; J Wignall; D Y Mochizuki; A Schmierer; B Mosley; C J March; D Urdal; S Gillis
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

Review 3.  Hematopoietic regulators: redundancy or subtlety?

Authors:  D Metcalf
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

4.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I.

Authors:  J I Jones; A J D'Ercole; C Camacho-Hubner; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells.

Authors:  S L Abboud; C R Bethel; D C Aron
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

6.  Human fatty marrow aromatizes androgen to estrogen.

Authors:  R E Frisch; J A Canick; D Tulchinsky
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

7.  Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.

Authors:  B R Westley; F E May
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

Review 8.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

9.  Insulin-like growth factor-I regulates pro-B cell differentiation.

Authors:  K S Landreth; R Narayanan; K Dorshkind
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

10.  Stepwise progression of B lineage differentiation supported by interleukin 7 and other stromal cell molecules.

Authors:  S Hayashi; T Kunisada; M Ogawa; T Sudo; H Kodama; T Suda; S Nishikawa; S Nishikawa
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  6 in total

1.  Long-term culture system for selective growth of human B-cell progenitors.

Authors:  D J Rawlings; S G Quan; R M Kato; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

2.  Bone marrow lymphoid and myeloid progenitor cells are suppressed in 7,12-dimethylbenz(a)anthracene (DMBA) treated mice.

Authors:  A U N'jai; M Larsen; L Shi; C R Jefcoate; C J Czuprynski
Journal:  Toxicology       Date:  2010-02-18       Impact factor: 4.221

3.  Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

Authors:  R N Pearse; E M Sordillo; S Yaccoby; B R Wong; D F Liau; N Colman; J Michaeli; J Epstein; Y Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

4.  Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan.

Authors:  T P Skelton; C Zeng; A Nocks; I Stamenkovic
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

5.  Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines.

Authors:  M Dorsch; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Impairment of T and B cell development by treatment with a type I interferon.

Authors:  Q Lin; C Dong; M D Cooper
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.